2001
DOI: 10.1177/147323000102900508
|View full text |Cite
|
Sign up to set email alerts
|

Successful Treatment of Patients with Rheumatic Disorders and Acquired Factor VIII Inhibitors with Cyclophosphamide and Prednisolone Combination Therapy: Two Case Reports

Abstract: Acquired haemophilia associated with autoimmune disorders can be fatal and has been reported to be refractory to steroid therapy alone. We report two cases of female patients, aged 24 years and 54 years, with acquired haemophilia caused by factor VIII inhibitors. Underlying diseases were systemic lupus erythematosus in the 24-year-old patient and rheumatoid arthritis in the 54-year-old patient. Both conditions were nearly quiescent when the patients manifested haemorrhagic diathesis. In response to combination… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
9
0
1

Year Published

2004
2004
2020
2020

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(10 citation statements)
references
References 15 publications
0
9
0
1
Order By: Relevance
“…The APTT was prolonged but other laboratory screenings for hemostasis such as the platelet count and PT were normal. Similar to cases 6 and 8, the inhibiting autoantibodies could even appear in patients with quiescent SLE [9,10,12], which suggests that the appearance of the FVIII inhibitor and its level does not always correlate with underlying disease activity. We could not find any other possible inductive factor(s) for our SLE patient to develop acquired hemophilia, such as other disease conditions (including skin and respiratory diseases), infections, and use of certain drugs (including penicillin and its derivatives).…”
Section: Discussionmentioning
confidence: 85%
See 1 more Smart Citation
“…The APTT was prolonged but other laboratory screenings for hemostasis such as the platelet count and PT were normal. Similar to cases 6 and 8, the inhibiting autoantibodies could even appear in patients with quiescent SLE [9,10,12], which suggests that the appearance of the FVIII inhibitor and its level does not always correlate with underlying disease activity. We could not find any other possible inductive factor(s) for our SLE patient to develop acquired hemophilia, such as other disease conditions (including skin and respiratory diseases), infections, and use of certain drugs (including penicillin and its derivatives).…”
Section: Discussionmentioning
confidence: 85%
“…Among previous investigations of acquired hemophilia along with SLE, nine cases (including our case) are available, and the features of these reported cases are summarized in Table 1 [4][5][6][7][8][9][10][11][12]. All cases were female patients of child-bearing age with a median age of 33.9 years (range, 19-54 years).…”
Section: Discussionmentioning
confidence: 93%
“…Among the previous investigations of acquired factor VIII inhibitors for patients with SLE, five case reports are available (7)(8)(9)(10)(11)(12), including the present case. These patients' histories are listed in Table 2.…”
Section: Discussionmentioning
confidence: 99%
“…15,18,22 Among previous investigations of acquired hemophilia along with SLE, ten cases (including our case) are available, and the features of these reported cases are summarized in Table 3. [19][20][21][22][23][24][25][26][27][28] As reported in other similar cases, a careful follow-up of the clotting tests is important to evaluate the response to therapy and the risk of new hemorrhagic manifestations. In our case normalization of the clotting tests were achieved after 6 month since the start of treatment which was enough monotheraphy with prednisolone, although other nine similar cases were needed combination therapy for controlling the disease.…”
Section: Discussionmentioning
confidence: 99%